Allergan and Rugen Therapeutics to jointly support novel therapies Autism Spectrum Disorders
Allergan plc, a company recently bought by Pfizer, and Rugen Therapeutics will jointly support the discovery and development of novel therapies for Autism Spectrum Disorders (ASD) and Obsessive Compulsive disorders (OCD).
You must be logged in to post a comment.